HomeCompaniesBrain Tumour Research (BTRC)

Brain Tumour Research (BTRC)

Brain Tumour Researchis a UK-based medical research charity dedicated to funding research, raising awareness of brain tumours. The charities vision is to find a cure for brain tumours of all kinds.

The charity works with and funds a network of experts in sustainable research at dedicated Centres of Excellence across the UK. The charity also focuses on influencing the Government and larger cancer charities to invest more nationally.

History

In 2004, an informal partnership of several regional UK charities working to raise funds for brain tumour research and support agreed to join forces under the banner of the United Brain Tumour Campaign, committing themselves to work together to increase awareness across the UK and achieve a common goal to raise funds specifically for research in the UK into the prevention and treatment of brain tumours.

The Diana Ford Trust, a charity funding brain tumour research, re-registered as Brain Tumour Research in 2008, using their cash deposits to fund first stage of a new national brain tumour research funding and awareness campaign. Brain Tumour Research was launched as a national charity in 2009.

Brain Tumour Research also acts as an umbrella organisation for a number of brain tumour charities throughout the UK.

Other companies

Trehearne & Norman
Trehearne & Norman
Trehearne & Norman is architecture company. History Orchard House was built in 1929 to 1930 to the design of the architectural practice Trehearne and Norman by the contractors Thomas and
Institute for Fiscal Studies (IFS)
Institute for Fiscal Studies (IFS)
The Institute for Fiscal Studies was founded in 1969. Established as an independent research institute, IFS was launched with the principal aim of better informing public debate on economics in o
CVC Capital Partners
CVC Capital Partners
CVC Capital Partners plc is a Jersey-based private equity and investment advisory firm with approximately €186 billion of assets under management and approximately €157 b